Загрузка...

Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells

Uterine cervical adenocarcinoma has a poor clinical prognosis when compared with squamous cell carcinoma. Therefore, the development of new treatment strategies for uterine cervical adenocarcinoma is necessary. Src is a proto-oncogene that is important in cancer progression. Dasatinib is a Src inhib...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Exp Ther Med
Главные авторы: Takiguchi, Eri, Nishimura, Masato, Mineda, Ayuka, Kawakita, Takako, Abe, Akiko, Irahara, Minoru
Формат: Artigo
Язык:Inglês
Опубликовано: D.A. Spandidos 2017
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5647549/
https://ncbi.nlm.nih.gov/pubmed/29067110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.5061
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!